Professor Jacob Sherkow has co-authored two blog posts for patent and IP blog, Written Description.
The first post evaluates multi-agency funding for COVID-19 vaccine development. Looking specifically at the vaccine in development by Moderna, Inc., the authors explore how these investments interact through different forms of research partnerships, and what this says about IP, novel technologies, and innovation policy. Read the full post at writtendescription.blogspot.com.
The second post unpacks why the Department of Health and Human Services is blocking the FDA from regulating some diagnostics, and how will this affect COVID-19 testing. Read the full post at writtendescription.blogspot.com.